We have a Patent Portfolio of Innovative Process Technology that Significantly Reduces Production Costs for Major Pharmaceuticals.
Thesis Chemistry & BioChemInsights Leverage Their Market Knowledge of the Need for Difficult Chemical Syntheses with Innovative Process Chemistry to Exploit Highly Profitable Chiral Fine Chemical Opportunities.
Each Business Opportunity is Screened According to Strict Criteria
Technical Assessment Complex Chemistry Chiral Molecules High-Value Fine Chemical
Competitive Landscape Analysis Market Size Major Players Product Life-cycle Stage
Intellectual Property Strength of Patent Portfolio Expiration LandscapeParagraph IV Situation
Please contact us with your requests and specific interests.
Our Proprietary Technology is in various stages of development depending upon the molecule. Some technology is at the utility patent stage with fully developed process technoogy ready for transfer to a commercial-scale plant while other processes could be as early as a provisional patent application based upon laboratory proof-of-concept and ready for process scale-up.
Our Proprietary Technology typically follows the steps below: Identify Suitable Manufacturing Process; Laboratory Proof-of-Concept; Development and Supply Agreement (Service Based); ·Process Technology Transfer to Production Plant; ·Supply of Advanced Intermediate or API.
For those projects that have completed the laboratory proof-of-concept, we typically enter into a service-based contract for the scale-up and subsequent technology transfer to the production at the appropriate scale to support the product needs in either early-stage or later-stage clinical trials. For late-stage clinicals and product launch, we transfer the technology to the commercial-scale palant and either supply the API under a supply agreement or license the technology to the production plant for a technology fee and royalty in production.
